Trials / Completed
CompletedNCT00344695
Bupropion Treatment for Youth Smoking Cessation
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Arizona · Academic / Other
- Sex
- All
- Age
- 14 Years – 17 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to 1) evaluate the safety and efficacy of two doses of bupropion SR (150mg/day and 300mg/day) when compared to placebo, as an aid to smoking cessation in adolescents and 2) to examine which factors, such as medication adherence, nicotine dependence, and motivation to quit, affect treatment outcome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bupropion SR |
Timeline
- Completion
- 2003-04-01
- First posted
- 2006-06-27
- Last updated
- 2006-06-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00344695. Inclusion in this directory is not an endorsement.